Jagsonpal Pharmaceuticals Announces Q4 FY26 Earnings Conference Call for Analysts
Jagsonpal Pharmaceuticals Ltd has scheduled an Investor and Analysts Conference Call to discuss the company's financial results for the fourth quarter of the fiscal year 2026 (Q4 FY26). The event is organized in part as part of the company's investor engagement activities.The conference call is scheduled for Tuesday, April 28, 2026, and will be hosted by Go India Advisors.
Key participants expected to address the investors include Manish Gupta, the Managing Director; Amrut Medhekar, the Chief Operating Officer; and Nirav Vora, the Chief Financial Officer.
Investors can dial in to the conference call using the universal dial-in numbers: +91 22 6280 1557 or +91 22 7115 8383. Participants are advised to dial in at least 5 to 10 minutes prior to the scheduled time of 3:00 PM IST to ensure connectivity.
JAGSNPHARM Stock Price Movement
Today, Jagsonpal Pharmaceuticals Limited shares edged higher, closing at ₹200.14, representing a gain of 2.04%. The stock finished trading on 195,208 shares, having navigated a daily range between ₹195.7 and ₹201.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.